Immunization, measles second dose (% of children by the nationally) in Ecuador
Ecuador: Immunization, measles second dose (% of children by the nationally) was 60.0% in 2024. ▼ Falling
Immunization, measles second dose in Ecuador, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Ecuador is 60.0%, measured in 2024.
The figure is up 1.7% over ten years.
Over the whole period, immunization, measles second dose in Ecuador peaked at 99.0% in 2009 and was at its lowest, 58.0%, in 2021.
That places Ecuador 155th out of 178 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 16 years of available data.
Immunization, measles second dose (% of children by the nationally) in Ecuador, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2009 | 99.0% | — |
| 2010 | 91.0% | -8.1% |
| 2011 | 92.0% | +1.1% |
| 2012 | 81.0% | -12.0% |
| 2013 | 70.0% | -13.6% |
| 2014 | 59.0% | -15.7% |
| 2015 | 76.0% | +28.8% |
| 2016 | 64.0% | -15.8% |
| 2017 | 73.0% | +14.1% |
| 2018 | 74.0% | +1.4% |
| 2019 | 76.0% | +2.7% |
| 2020 | 70.0% | -7.9% |
| 2021 | 58.0% | -17.1% |
| 2022 | 60.0% | +3.4% |
| 2023 | 60.0% | +0.0% |
| 2024 | 60.0% | +0.0% |
Ecuador compared with similar countries
- Ecuador's 60.0% is below the median for upper middle income countries, which is 84.5%, 71% of the median. (56 countries reporting)
- Ecuador's 60.0% is below the median for Latin America & Caribbean, which is 77.0%, 78% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 99.0% | 99.0% | 99.0% | 1 |
| 2010s | 75.6% | 59.0% | 92.0% | 10 |
| 2020s | 61.6% | 58.0% | 70.0% | 5 |
Countries ranked near Ecuador
More health data for Ecuador
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6766 % change on previous year (2090)
- Un projection of annual infant deaths 354 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0362 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0378 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in Ecuador?
- Immunization, measles second dose in Ecuador was 60.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Ecuador?
- The highest recorded value was 99.0% in 2009.
- What is the lowest immunization, measles second dose recorded in Ecuador?
- The lowest recorded value was 58.0% in 2021.
- How does Ecuador rank for immunization, measles second dose?
- Ecuador ranks 155th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Ecuador?
- Over the last ten years it is up 1.7%. The long-run trend across the full record is falling.
- Where does this Ecuador data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.